This is a $12,060 firm-fixed-price purchase order awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics and scientific equipment. The contract is for maintenance services on Qiagen's EZ2 Connect and QIAcuity One instruments used for isolation and analysis of cell-free DNA. The contract has an ultimate completion date of August 15, 2026. Qiagen has established itself as a critical...
This is a firm fixed-price purchase order awarded by the National Institutes of Health (NIH) National Heart Lung and Blood Institute to Qiagen, LLC, a division of the international provider Qiagen N.V. The contract is for a maintenance service agreement to maintain the Qiasymphony SP 34311 equipment used for isolating cell-free DNA from plasma samples of lung transplant patients. The period of performance is from August 1, 2024 to July 31, 2025, with a potential value of $13,268.65. Qiagen is...
This is a $24,978.80 firm fixed-price purchase order awarded by the National Heart Lung and Blood Institute, part of the Department of Health and Human Services, to Qiagen, LLC, a foreign-owned for-profit manufacturer of molecular diagnostic products. The contract requires Qiagen to provide QIAsymphony DSP circulating DNA kits to isolate cell-free DNA from plasma samples from lung transplant patients. This is likely in support of the agency's biomedical research and public health programs. The...
This firm-fixed-price purchase order was awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency within the U.S. Department of Health and Human Services, to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics, scientific equipment, and bioinformatics solutions. The $24,882.55 contract is for the NHLBI's Laboratory of Applied Precision Omics to acquire Qiagen's QIAsymphony DSP Circulating DNA Kit to isolate cell-free DNA from plasma samples...
This is a $13,858 firm fixed-price purchase order awarded by the Office of Acquisitions and Grants, a civilian federal agency, to Qiagen, LLC, a foreign-owned for-profit manufacturer and global provider of sample and assay technologies for molecular diagnostics, applied testing, pharmaceuticals, and academic research. The contract is for the maintenance of QIAGEN laboratory equipment. It does not have a set-aside designation and has an ultimate completion date of May 14, 2028. Qiagen is a...
This is a federal contract award (75N90025P00400) issued by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a foreign-owned for-profit manufacturer of molecular diagnostic and life sciences products. The contract, valued at $30,071.70, is for a 12-month period of performance and includes the provision of Qiagen's QIAGILITY and QIASYMPHONY SP instruments and associated maintenance services. The contract is not associated with a set-aside program. Qiagen has previously been...
The National Institutes of Health National Heart, Lung and Blood Institute awarded a firm fixed price purchase order valued at twelve thousand four hundred dollars and thirty-five cents ($12,400.35) to Qiagen, LLC for maintenance service of a QIASYMPHONY SP 34311 instrument. The contract requires Qiagen to maintain equipment used by the Laboratory of Applied Precision Omics to isolate cell-free DNA from plasma samples of lung transplant patients. Performance will occur in Germantown, Maryland...
This is a firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics and laboratory equipment. The $11,333.80 contract is for the delivery of specialized products and services, including DNA/RNA extraction kits, next-generation sequencing equipment, digital PCR systems, sample preparation instruments, precision medicine analysis tools, and bioinformatics software. Qiagen...
This is a $33,368.50 firm fixed price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a foreign-owned for-profit manufacturer. The contract is for the provision of DNA isolation kits from November 1, 2024 to September 30, 2025. The award is not associated with a set-aside program. Qiagen has a history of providing a range of products and services to support federal agencies' biomedical research, public health, law enforcement, and healthcare...
This federal contract award was issued by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics, scientific equipment, and bioinformatics solutions. The $11,343.80 firm fixed-price purchase order is for QIASEQ TARGETED DNA CUSTOM PANEL (96) - 6601-6700, CDHS-47388Z-6699 products. The contract has an ultimate completion date of September 27, 2025. Qiagen, LLC is a division of the international biotechnology...